Free Trial

522 Shares in Axon Enterprise, Inc (NASDAQ:AXON) Bought by Kesler Norman & Wride LLC

Axon Enterprise logo with Aerospace background

Kesler Norman & Wride LLC purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 522 shares of the biotechnology company's stock, valued at approximately $275,000.

Other large investors have also made changes to their positions in the company. Capital World Investors grew its holdings in shares of Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after buying an additional 841,772 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after buying an additional 812,337 shares in the last quarter. Norges Bank purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $482,081,000. GQG Partners LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $478,349,000. Finally, GAMMA Investing LLC grew its holdings in shares of Axon Enterprise by 58,725.5% during the first quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock worth $402,210,000 after buying an additional 763,431 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the transaction, the chief accounting officer owned 15,240 shares of the company's stock, valued at $11,762,384.40. This trade represents a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Joshua Isner sold 905 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the transaction, the president directly owned 268,735 shares in the company, valued at approximately $208,643,166.65. This represents a 0.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock worth $30,500,428 in the last 90 days. 5.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on AXON. Barclays raised their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Bank of America raised their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They issued an "outperform" rating on the stock. Finally, Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the company an "overweight" rating in a research report on Friday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $716.36.

Read Our Latest Stock Report on AXON

Axon Enterprise Stock Down 0.6%

Shares of AXON stock traded down $4.39 during trading on Tuesday, hitting $745.87. 373,295 shares of the company were exchanged, compared to its average volume of 706,046. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83. The firm has a market capitalization of $58.07 billion, a price-to-earnings ratio of 180.16, a P/E/G ratio of 83.99 and a beta of 1.29. The business's 50-day simple moving average is $752.67 and its 200 day simple moving average is $641.14. Axon Enterprise, Inc has a twelve month low of $279.02 and a twelve month high of $830.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The business had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the previous year, the business earned $1.15 EPS. Axon Enterprise's quarterly revenue was up 31.3% compared to the same quarter last year. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines